清除烟雾:什么可以保护吸烟者免受帕金森病的影响?
Kenneth N Rose1, Michael A Schwarzschild1, Stephen N Gomperts1
1Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
概括
吸烟可能会降低帕金森病 (PD) 的风险,但尼古丁
科学领域:
- 神经流行病学神经流行病学
- 神经退行发生神经退行.
- 帕金森病 (PD) 的研究.
背景情况:
- 吸烟与降低帕金森病 (PD) 风险之间的确立联系是神经流行病学中的一个重要发现.
- 虽然尼古丁已被研究过,但临床试验并未表明它对PD具有神经保护作用.
- 除了尼古丁之外的替代机制可能解释吸烟对PD的潜在保护作用.
结论:
- 对烟雾中非尼古丁化合物的进一步研究对于了解PD预防至关重要.
- 研究吸烟引发的替代分子途径和生化级联是必要的.
- 在PD模型和临床试验中对这些化合物的严格评估可能会揭示疾病修饰疗法.
相关概念视频
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


